Results 251 to 260 of about 360,402 (292)

HDL‐C/LDL‐C Ratio and All‐Cause Mortality in Populations at High CVD Risk: A Prospective Observational Cohort Study

Chronic Diseases and Translational Medicine, EarlyView.
ABSTRACT Background The ratio of high‐density lipoprotein cholesterol (HDL‐C) to low‐density lipoprotein cholesterol (LDL‐C) predicts cardiovascular disease (CVD) endpoints, yet its prognostic validity in high‐risk populations and for type 2 diabetes mellitus (T2DM)‐related adverse events remains unestablished. Methods This study included 32,609 people
Biting Lin, Yunzhi Ling, Gengyu Zhou, Ziqing Ruan, Fan Chen, Simiao Chen, Tingting Weng, Yuanfan Zhu, Jingyi Lin, Ling Yu, Kaiyang Lin   +10 more
wiley   +1 more source

Development and validation of a risk score in acute myocardial infarction-related cardiogenic shock. [PDF]

Eur Heart J Acute Cardiovasc Care
Peters EJ, Kunkel JB, Bogerd M, Ten Berg S, Timmermans MJC, Helgestad OKL, Ravn HB, Kraaijeveld AO, Otterspoor LC, Sjauw KD, Lipšic E, Engström AE, Vlaar APJ, Hassager C, Møller JE, Henriques JPS.   +15 more
europepmc   +1 more source

Luminescence and Electroanalytical Properties of Carbon Quantum Dots in the Context of Immunosensor Design

ChemElectroChem, Volume 12, Issue 6, March 15, 2025.
Two types of carbon quantum dots (CQD‐COOH and CQD‐NH2) are used to modify screen printed carbon electrodes, for detection of Cardiac Troponin I (cTnI). These modified sensors offer promising results for the determination of cTnI in the picomolar range, when, using an immunosensor protocol.
Yemataw Addis Alemu, Clementine J Louw, Francesco Paolucci, Giovanni Valenti, Priscilla G L Baker   +4 more
wiley   +1 more source

Identification of mitophagy-related genes in patients with acute myocardial infarction. [PDF]

Hereditas
Li JY, Chen HK, Huang YH, Zhi YP, Li YE, Lin KY, Chen C, Guo YS.   +7 more
europepmc   +1 more source

Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining Challenges

Clinical Pharmacology &Therapeutics, EarlyView.
Barriers to incorporating pharmacogenetics into routine clinical practice in the United States are well documented. Initial surveys by the Clinical Pharmacogenetics Implementation Consortium (CPIC) in 2009 and 2010 identified barriers across four key domains that have hindered the widespread adoption of clinical pharmacogenetic testing.
D. Max Smith, Michael P. Douglas, Christina L. Aquilante, Patricia A. Deverka, Beth Devine, Henry M. Dunnenberger, Philip E. Empey, Daniel L. Hertz, Andrew A. Monte, Ann M. Moyer, Jai N. Patel, Victoria M. Pratt, Loren Saulsberry, Stuart A. Scott, Deepak Voora, Erica L. Woodahl, Michelle Whirl‐Carrillo, Akinyemi Oni‐Orisan, on behalf of the Pharmacogenomics Global Research Network (PGRN) Publications Committee   +18 more
wiley   +1 more source

Unveiling the Cardioprotective Potential of Hydroxytyrosol: Insights from an Acute Myocardial Infarction Model. [PDF]

Antioxidants (Basel)
Bermúdez-Oria A, Godoy E, Pérez V, Musci Ferrari C, Donato M, Fernández-Bolaños J, Zaobornyj T, D'Annunzio V.   +7 more
europepmc   +1 more source

Study on the association between neovascularization of culprit lesions and plaque rupture in patients with acute myocardial infarction. [PDF]

BMC Cardiovasc Disord
Zhang L, Deng C, Zhang W, Li X, Xia J, Yang C, Zhou L, Shi B, Xu G.   +8 more
europepmc   +1 more source

Fully Automated Diagnosis of Acute Myocardial Infarction Using Electrocardiograms and Multimodal Deep Learning. [PDF]

JACC Adv
Hilgendorf L, Petursson P, Andersson E, Rawshani A, Bhatt DL, Råmunddal T, Gupta V, Skoglund K, Omerovic E, Sjöland H, Taha A, Kim D, Lundgren P, Rawshani A.   +13 more
europepmc   +1 more source

Copeptin in Acute Myocardial Infarction: Is There a Role in the Era of High-Sensitivity Troponins? [PDF]

J Cardiovasc Dev Dis
Bezati S, Ventoulis I, Bistola V, Verras C, Matsiras D, Polyzogopoulou E, Parissis J.   +6 more
europepmc   +1 more source